As of 28 Aug 2026, Parenteral Drugs (India) Ltd share price is ₹3.39. The stock opened at ₹3.39 and had closed at ₹3.24 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹3.39 and a high of ₹3.39. In terms of performance, Parenteral Drugs (India) Ltd share price has increased by 0.00% over the past six months and has increased by 0.00% over the last year.
PDPL Charts
Parenteral Drugs (India) Ltd Overview
About PDPL
Parenteral Drugs (India) Company engaged primarily in the business of Manufacturing of Pharmaceutical Product. The Company is also engaged in trading in various products.
Parenteral Drugs (India) Ltd Historical Performance
Parenteral Drugs (India) Ltd Fundamental Analysis
Parenteral Drugs (India) Ltd Financials
| Indicator | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|
| Revenue | 1.81 | 1.45 | 2.36 | 2.94 | 2.60 |
| EBITDA | 46.36 | -3.22 | -3.25 | -2.62 | 3.42 |
| Net Profit | 23.81 | -34.52 | -33.61 | -32.04 | -24.84 |
| EPS | 7.99 | -11.58 | -11.28 | -10.74 | -8.33 |
Parenteral Drugs (India) Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | - |
| MACD | - |
| 20-Day SMA | - |
Parenteral Drugs (India) Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Parenteral Drugs (India) Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Parenteral Drugs (India) Ltd today is ₹3.39 on NSE and ₹3.39 on BSE.
- The 52-week high of Parenteral Drugs (India) Ltd is N/A, while the 52-week low is N/A.
- The current market capitalisation of Parenteral Drugs (India) Ltd is approximately ₹10 crore.
- The P/E (Price-to-Earnings) ratio of Parenteral Drugs (India) Ltd is -0.13. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Parenteral Drugs (India) Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Parenteral Drugs (India) Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Parenteral Drugs (India) Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Parenteral Drugs (India) Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Parenteral Drugs (India) Ltd comprises different categories of shareholders. As of Mar 2022, the shareholding is approximately 73.29% promoters, 0.00% FIIs, 0.00% DIIs, and 21.74% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
